In breast cancer, the case-control study for the SNPs or LOH of MIIP, and the association between MIIP expression and clinical prognosis factors or cell biologic behaviors suggested the involvement of MIIP in breast cancer development and progression [4, 5, 35]. This evidence concerns the gene MIIP and breast carcinoma.